AR and breast carcinoma: While these discoveries have important implications on the targeting of signaling pathways, molecular targets and miRNAs themselves in breast cancer and QNBC, evidence for strong associations of specific miRNAs and downstream pathways are newly emergent and require focused investigation to delineate new targets and treatment options for AR-positive versus AR-negative disease.